SYNACT PHARMA ApS — Credit Rating and Financial Key Figures

SYNACT PHARMA ApS (CVR number: 34459975) is a company from RUDERSDAL. The company recorded a gross profit of -26274.9 kDKK in 2024. The operating profit was -36 mDKK, while net earnings were -30.5 mDKK. The profitability of the company measured by Return on Assets (ROA) was -111.1 %, which can be considered poor and Return on Equity (ROE) was -149.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 66.4 %, a level that can be considered to be good. This shows that a large part of the company's assets are funded by shareholders' equity, reducing financial risk. SYNACT PHARMA ApS's liquidity measured by quick ratio was 2.6 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.